Detection of activities of daily living impairment in Alzheimer's disease and mild cognitive impairment using information and communication technology

por Sacco G, Joumier V, Darmon N, Dechamps A, Derreumaux A, Lee JH, Piano J, Bordone N, Konig A, Teboul B, David R, Guerin O, Bremond F, Robert P
Publicado 2012

A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease

por Giau VV, Pyun JM, Bagyinszky E, An SSA, Kim SY
Publicado 2018

Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer’s Disease Neuroimaging Initiative)

por Harris P, Fernandez Suarez M, Surace EI, Chrem Méndez P, Martín ME, Clarens MF, Tapajóz F, Russo MJ, Campos J, Guinjoan SM, Sevlever G, Allegri RF
Publicado 2015

Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer’s Disease Neuroimaging Initiative

por Russo MJ, Cohen G, Chrem Mendez P, Campos J, Nahas FE, Surace EI, Vazquez S, Gustafson D, Guinjoan S, Allegri RF, Sevlever G
Publicado 2016

Estrogen receptor α gene polymorphisms and risk of Alzheimer’s disease: evidence from a meta-analysis

por Cheng D, Liang B, Hao Y, Zhou W
Publicado 2014

Brain ischemia and ischemic blood–brain barrier as etiological factors in sporadic Alzheimer’s disease

por Ryszard Pluta, Marzena Utamek, Poland
Publicado 2008

Dual-targeted carbon-dot-drugs nanoassemblies for modulating Alzheimer's related amyloid-β aggregation and inhibiting fungal infection

por Chaoren Yan, Chaoli Wang, Xu Shao, Qi Shu, Xiaoling Hu, Ping Guan, Yonggang Teng, Yuan Cheng
Publicado 2021

Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer’s disease

por Li W, Wang T, Xiao S
Publicado 2016

Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease

por Martin Dyrba, Moritz Hanzig, Slawek Altenstein, Sebastian Bader, Tommaso Ballarini, Frederic Brosseron, Katharina Buerger, Daniel Cantré, Peter Dechent, Laura Dobisch, Emrah Düzel, Michael Ewers, Klaus Fliessbach, Wenzel Glanz, John-Dylan Haynes, Michael T. Heneka, Daniel Janowitz, Deniz B. Keles, Ingo Kilimann, Christoph Laske, Franziska Maier, Coraline D. Metzger, Matthias H. Munk, Robert Perneczky, Oliver Peters, Lukas Preis, Josef Priller, Boris Rauchmann, Nina Roy, Klaus Scheffler, Anja Schneider, Björn H. Schott, Annika Spottke, Eike J. Spruth, Marc-André Weber, Birgit Ertl-Wagner, Michael Wagner, Jens Wiltfang, Frank Jessen, Stefan J. Teipel, for the ADNI, AIBL, DELCODE study groups
Publicado 2021

Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology

por A. Ahnaou, D. Moechars, L. Raeymaekers, R. Biermans, N. V. Manyakov, A. Bottelbergs, C. Wintmolders, K. Van Kolen, T. Van De Casteele, J. A. Kemp, W. H. Drinkenburg
Publicado 2017

Multimodal, label-free fluorescence and Raman imaging of amyloid deposits in snap-frozen Alzheimer’s disease human brain tissue

por Benjamin Lochocki, Baayla D. C. Boon, Sander R. Verheul, Liron Zada, Jeroen J. M. Hoozemans, Freek Ariese, Johannes F. de Boer
Publicado 2021

Ameliorative potential of desalted Salicornia europaea L. extract in multifaceted Alzheimer’s-like scopolamine-induced amnesic mice model

por Govindarajan Karthivashan, Shin-Young Park, Mee-Hyang Kweon, Joonsoo Kim, Md. Ezazul Haque, Duk-Yeon Cho, In-Su Kim, Eun-Ah Cho, Palanivel Ganesan, Dong-Kug Choi
Publicado 2018

Gene Set Index Based on Different Modules May Help Differentiate the Mechanisms of Alzheimer’s Disease and Vascular Dementia

por Zhou F, Chen D, Chen G, Liao P, Li R, Nong Q, Meng Y, Zou D, Li X
Publicado 2021

Repetitive Transcranial Magnetic Stimulation for Alzheimer’s Disease Based on Apolipoprotein E Genotyping: Protocol for a Randomized Controlled Study

por Naili Wei, Jian Chen
Publicado 2021

G-quadruplexes originating from evolutionary conserved L1 elements interfere with neuronal gene expression in Alzheimer’s disease

por Roy Hanna, Anthony Flamier, Andrea Barabino, Gilbert Bernier
Publicado 2021

A logical network-based drug-screening platform for Alzheimer’s disease representing pathological features of human brain organoids

por Jong-Chan Park, So-Yeong Jang, Dongjoon Lee, Jeongha Lee, Uiryong Kang, Hongjun Chang, Haeng Jun Kim, Sun-Ho Han, Jinsoo Seo, Murim Choi, Dong Young Lee, Min Soo Byun, Dahyun Yi, Kwang-Hyun Cho, Inhee Mook-Jung
Publicado 2021

Perfiles neuropsicológicos: Enfermedad de Alzheimer y Parkinson, Deterioro cognitivo leve, Trastorno depresivo mayor y Envejecimiento.

por Ana Miranda, Marlene Pruvost, Fátima González Palau, María Florencia Rimoldi, Magdalena Viale, Magdalena Cáceres
Publicado 2015

The efficacy of mirtazapine in agitated patients with Alzheimer’s disease: A 12-week open-label pilot study

por Sibel Cakir, Isin Baral Kulaksizoglu
Publicado 2008

Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population

por Wu P, Li HL, Liu ZJ, Tao QQ, Xu M, Guo QH, Hong Z, Sun YM
Publicado 2015

Quantitative Brain Positron Emission Tomography in Female 5XFAD Alzheimer Mice: Pathological Features and Sex-Specific Alterations

por Caroline Bouter, Caroline Irwin, Timon N. Franke, Nicola Beindorff, Yvonne Bouter
Publicado 2021